introduction: post cardiac surgery hemorrhagic syndromes, potentialized by implementing   cardiopulmonary bypass, leads to increased hazards of blood products transfusion and          pertains serious impacts on immediate patients outcome. the objective of this clinical trial was to investigate the efficiency of exogenous fibrinogen to control hemorrhagic syndromes following cardiac surgery in ...